Participants 79 141 3
nondiabetic patients with stage I or II chronic kidney disease
Participants 736 848 4
Thirty nondiabetic stage I or II CKD patients who had already been treated with angiotensin II receptor blockers
Participants 1004 1048 4
Patients were randomly divided into 2 groups
